MX2010004457A - Idarubicina para el tratamiento de linfoma en un perro. - Google Patents

Idarubicina para el tratamiento de linfoma en un perro.

Info

Publication number
MX2010004457A
MX2010004457A MX2010004457A MX2010004457A MX2010004457A MX 2010004457 A MX2010004457 A MX 2010004457A MX 2010004457 A MX2010004457 A MX 2010004457A MX 2010004457 A MX2010004457 A MX 2010004457A MX 2010004457 A MX2010004457 A MX 2010004457A
Authority
MX
Mexico
Prior art keywords
dog
idarubicin
lymphoma
treatment
administering
Prior art date
Application number
MX2010004457A
Other languages
English (en)
Inventor
Pamela Jo Berlinski
Steven Glenn Kamerling
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MX2010004457A publication Critical patent/MX2010004457A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

La presente invención se refiere a un procedimiento para tratar un linfoma en un perro que comprende administrar a un perro que necesita dicho tratamiento una cantidad terapéuticamente eficaz de idarubicina o una de sus sales farmacéuticamente aceptables.
MX2010004457A 2007-10-26 2008-10-15 Idarubicina para el tratamiento de linfoma en un perro. MX2010004457A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98284307P 2007-10-26 2007-10-26
PCT/IB2008/002783 WO2009053804A2 (en) 2007-10-26 2008-10-15 Idarubicin for the treatment of lymphoma in a dog

Publications (1)

Publication Number Publication Date
MX2010004457A true MX2010004457A (es) 2010-05-03

Family

ID=40437273

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004457A MX2010004457A (es) 2007-10-26 2008-10-15 Idarubicina para el tratamiento de linfoma en un perro.

Country Status (12)

Country Link
US (1) US20100234314A1 (es)
EP (1) EP2211869A2 (es)
JP (1) JP2009108058A (es)
KR (1) KR20100058662A (es)
CN (1) CN101835474A (es)
AR (1) AR069008A1 (es)
AU (1) AU2008315718A1 (es)
BR (1) BRPI0818860A2 (es)
CA (1) CA2703149A1 (es)
MX (1) MX2010004457A (es)
WO (1) WO2009053804A2 (es)
ZA (1) ZA201002769B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2508207T3 (da) * 2011-03-31 2013-07-29 Bioalliance Pharma Nanopartikler ladet med kemoterapeutisk antitumormiddel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
BRPI0818860A2 (pt) 2015-04-22
CA2703149A1 (en) 2009-04-30
AU2008315718A1 (en) 2009-04-30
AR069008A1 (es) 2009-12-23
ZA201002769B (en) 2011-04-28
WO2009053804A3 (en) 2009-06-11
KR20100058662A (ko) 2010-06-03
US20100234314A1 (en) 2010-09-16
JP2009108058A (ja) 2009-05-21
EP2211869A2 (en) 2010-08-04
CN101835474A (zh) 2010-09-15
WO2009053804A2 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
HK1120441A1 (en) Drugs for treatment of ovarian cancer
MX342001B (es) Tratamiento de artritis por lupus usando laquinimod.
MX337614B (es) Tratamiento de lupus nefritis usando laquinimod.
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2007085019A3 (en) Methods of treating or preventing sinusitis with oxidative reductive potential water solution
MY150797A (en) Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
MX350745B (es) El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
MX338099B (es) Perhexilina para usarla en el tratamiento de miocardiopatía hipertrófica (hcm).
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
TW200806299A (en) Treatment of pain
NZ602478A (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
MX2008012479A (es) Tratamiento de enfermedades neurodegenerativas.
IL201422A0 (en) Therapeutic agents useful for treating pain
GT200600160A (es) Tratamiento del dolor
WO2007022408A3 (en) Combination methods of saha and targretin for treating cancer
AR093182A1 (es) Metodo para tratar el sobrepeso o la obesidad
CA2632207C (en) Use of calcitonin for the treatment of ra
EA201270071A1 (ru) Способ лечения пациента, нуждающегося в аспириновой терапии
SG179192A1 (en) Methods for treating brain tumors
SG10201405392RA (en) Method of treatment of neurodegenerative or neuro-muscular degenerative diseases andtherapeutic agent to treat the same
TW200742580A (en) Methods for treating nephrolithiasis
TN2009000490A1 (en) Cancer treatment combination therapy comprising vinflunine and trastuzumab
MX2010002032A (es) Uso de flibanserina para el tratamiento de sintomas vasomotores.
WO2007149543A3 (en) Scar treatment using protein phosphatase inhibitors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal